ARCHIVES

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Another Potti Paper Retracted

September 16, 2011

Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations

August 31, 2001

Cell Culture ID Offered By NIC

January 7, 1983

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005

Letters to The Editors: Donald Coffey Finds Sensationalism Hurts

June 6, 1997

In Brief: William McGuire, Breast Cancer Researcher, Dead of Heart Attack; Attracted Large Group To Texas

April 10, 1992